These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 2761681)
1. Muscarinic receptor plasticity in rats lesioned in the nucleus basalis of Meynert. Vige X; Briley M Neuropharmacology; 1989 Jul; 28(7):727-32. PubMed ID: 2761681 [TBL] [Abstract][Full Text] [Related]
2. Scopolamine induces up-regulation of nicotinic receptors in intact brain but not in nucleus basalis lesioned rats. Vige X; Briley M Neurosci Lett; 1988 Jun; 88(3):319-24. PubMed ID: 3386878 [TBL] [Abstract][Full Text] [Related]
3. Effects of bilateral ibotenate-induced lesions of the nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the rat anterior cerebral cortex. Watson M; Vickroy TW; Fibiger HC; Roeske WR; Yamamura HI Brain Res; 1985 Nov; 346(2):387-91. PubMed ID: 3840399 [TBL] [Abstract][Full Text] [Related]
4. Recovery of neocortical choline acetyltransferase activity following ibotenic acid injection into the nucleus basalis of Meynert in rats. Wenk GL; Olton DS Brain Res; 1984 Feb; 293(1):184-6. PubMed ID: 6704718 [TBL] [Abstract][Full Text] [Related]
5. Colchicine administered into the area of the nucleus basalis decreases cortical nicotinic cholinergic receptors labelled by [3H]-acetylcholine. Tilson HA; Schwartz RD; Ali SF; McLamb RL Neuropharmacology; 1989 Aug; 28(8):855-61. PubMed ID: 2779754 [TBL] [Abstract][Full Text] [Related]
6. Effect of prolonged co-dergocrine mesylate treatment on choline acetyltransferase levels in rat cerebral cortex after lesioning of the nucleus basalis magnocellularis (of Meynert). Amenta D; De Rossi M; Amenta F Pharmacol Res Commun; 1988 Sep; 20(9):799-810. PubMed ID: 3174805 [TBL] [Abstract][Full Text] [Related]
7. Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert. Aigner TG; Mitchell SJ; Aggleton JP; DeLong MR; Struble RG; Price DL; Wenk GL; Mishkin M Psychopharmacology (Berl); 1987; 92(3):292-300. PubMed ID: 3114781 [TBL] [Abstract][Full Text] [Related]
8. Effects of nBM lesions on muscarinic-stimulation of phosphoinositide hydrolysis. Raulli RE; Arendash G; Crews FT Neurobiol Aging; 1989; 10(2):191-7. PubMed ID: 2542819 [TBL] [Abstract][Full Text] [Related]
9. Are the neurochemical and behavioral changes induced by lesions of the nucleus basalis in the rat a model of Alzheimer's disease? Pepeu G; Casamenti F; Pedata F; Cosi C; Pepeu IM Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):541-51. PubMed ID: 2879319 [TBL] [Abstract][Full Text] [Related]
10. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218 [TBL] [Abstract][Full Text] [Related]
11. Choline acetyltransferase activity in the rat brain cortex homogenate, synaptosomes, and capillaries after lesioning the nucleus basalis magnocellularis. Santos-Benito FF; González JL; de la Torre F J Neurochem; 1988 Feb; 50(2):395-9. PubMed ID: 3335856 [TBL] [Abstract][Full Text] [Related]
12. Further characterizations of the nature of the behavioral and neurochemical effects of lesions to the nucleus basalis of Meynert in the rat. Altman HJ; Crosland RD; Jenden DJ; Berman RF Neurobiol Aging; 1985; 6(2):125-30. PubMed ID: 4022231 [TBL] [Abstract][Full Text] [Related]
13. A subcortico-cortical cholinergic system is affected in Parkinson's disease. Dubois B; Ruberg M; Javoy-Agid F; Ploska A; Agid Y Brain Res; 1983 Dec; 288(1-2):213-8. PubMed ID: 6661617 [TBL] [Abstract][Full Text] [Related]
14. Effects of scopolamine treatment and lesion of the nucleus basalis upon various cholinergic markers in the rat brain cortex. Moret C; Pastrie I; Briley M Neurochem Int; 1989; 15(3):333-7. PubMed ID: 20504503 [TBL] [Abstract][Full Text] [Related]
15. Effects of nucleus basalis lesions on the muscarinic and nicotinic modulation of [3H]acetylcholine release in the rat cerebral cortex. Meyer EM; Arendash GW; Judkins JH; Ying L; Wade C; Kem WR J Neurochem; 1987 Dec; 49(6):1758-62. PubMed ID: 3681294 [TBL] [Abstract][Full Text] [Related]
16. A glutamatergic innervation of the nucleus basalis/substantia innominata. Davies SW; McBean GJ; Roberts PJ Neurosci Lett; 1984 Mar; 45(1):105-10. PubMed ID: 6328369 [TBL] [Abstract][Full Text] [Related]
17. Unilateral and bilateral nucleus basalis lesions: differences in neurochemical and behavioural recovery. Casamenti F; Di Patre PL; Bartolini L; Pepeu G Neuroscience; 1988 Jan; 24(1):209-15. PubMed ID: 3368050 [TBL] [Abstract][Full Text] [Related]
18. Changes in cholinergic but not in GABAergic markers in amygdala, piriform cortex, and nucleus basalis of the rat brain following systemic administration of kainic acid. Schliebs R; Zivin M; Steinbach J; Rothe T J Neurochem; 1989 Jul; 53(1):212-8. PubMed ID: 2542459 [TBL] [Abstract][Full Text] [Related]
19. Effect of vagal autotransplantation and bifemelane hydrochloride on cholinergic markers and event-related potentials in rats with lesions of the nucleus basalis magnocellularis. Ikeda K; Egashira T; Yamashita J; Okoyama S Brain Res; 1995 Aug; 688(1-2):171-83. PubMed ID: 8542304 [TBL] [Abstract][Full Text] [Related]
20. Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers. Mandel RJ; Chen AD; Connor DJ; Thal LJ J Pharmacol Exp Ther; 1989 Nov; 251(2):612-9. PubMed ID: 2810114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]